fluconazole has been researched along with Cardiac Hypertrophy in 2 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Shoieb, SM | 2 |
Alammari, AH | 2 |
Levasseur, J | 1 |
Silver, H | 1 |
Dyck, JRB | 1 |
El-Kadi, AOS | 2 |
Maayah, ZH | 1 |
2 other studies available for fluconazole and Cardiac Hypertrophy
Article | Year |
---|---|
Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction-Induced Cardiac Hypertrophy in Rats.
Topics: Animals; Cardiomegaly; Constriction; Fluconazole; Hydroxyeicosatetraenoic Acids; Hypertrophy, Left V | 2022 |
Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Arachidonic Acid; Cardiomegaly; Cytochrome P-450 Enzyme System; Fluconazole | 2020 |